Furthermore, increasing drug approvals from regulatory authorities and product launches are expected to drive the market growth. For instance, in November 2014, Sandoz, the generic pharmaceuticals division of Novartis, launched Vitaros, an innovative topical therapy for erectile dysfunction (ED), in Sweden.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients